Illumina Stock Price - ILMN

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 326.47 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  6.66 2.08% 326.47 328.325 319.644 321.00 319.81 19:59:40
Bid Price Ask Price Spread Spread % News
310.00 350.00 40.00 11.43% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
14,635 952,247 $ 325.79 $ 310,233,512 979,782 263.30 - 380.9999
Last Trade Time Type Quantity Stock Price Currency
19:50:49 1 $ 327.00 USD

Illumina Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 47.99B 147.00M $ 826.00M 5.56 46.40 143.99M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Illumina News

Loading Messages....

Latest ILMN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ILMN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week320.00328.39315.515320.54604,0546.472.02%
1 Month293.00328.39290.26311.19702,74133.4711.42%
3 Months299.74328.39279.76303.16868,67926.738.92%
6 Months318.18380.9999263.30307.321,021,8038.292.61%
1 Year327.50380.9999263.30306.76986,130-1.03-0.31%
3 Years127.92380.9999119.37255.19944,621198.55155.21%
5 Years189.15380.9999119.37214.191,106,332137.3272.6%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.